No Prescription |
 |
 | ||
|
Advantan Lotion Generic Methylprednisolone aceponate |
|
| ||
No Prescription » Prescription Drugs 1 » Advantan Lotion Generic Methylprednisolone aceponate The active ingredient in Advantan(R) belongs to the group of medicines called corticosteroids. The corticosteroid in Advantan(R) is suitable to put on the skin. It is therefore called a topical corticosteroid which is sometimes shortened to topical steroid.When Advantan(R) is put on the skin it relieves the redness swelling itching and irritation of the skin in eczema and psoriasis. Buy Advantan Lotion Generic Methylprednisolone aceponate and other Prescription Drugs 1 products online at Medstore. Buy Online at Medstore - Click Here!
About Advantan Lotion Generic Methylprednisolone aceponate: Product Type: Prescription Drugs 1 Advantan Lotion ( Generic Methylprednisolone aceponate ) Product Origin: EU ( Turkey ) Advantan Lotion (Generic Methylprednisolone aceponate) Generic Methylprednisolone aceponate 0.1% 50gm 150gm Generic Methylprednisolone aceponate Advantan Lotion
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
